NVO vs. CW8U.L
NVO (Novo Nordisk A/S) is a stock, while CW8U.L (Amundi MSCI World UCITS USD) is Global Equities fund tracking the MSCI ACWI NR USD. Over the past 5 years, NVO returned 2.92%/yr vs 11.24%/yr for CW8U.L. At a 0.21 correlation, their price movements are largely independent.
Performance
NVO vs. CW8U.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a -10.74% return, which is significantly lower than CW8U.L's 8.47% return.
NVO
- 1D
- -0.18%
- 1M
- -4.19%
- YTD
- -10.74%
- 6M
- -9.50%
- 1Y
- -42.47%
- 3Y*
- -15.59%
- 5Y*
- 2.92%
- 10Y*
- 7.56%
CW8U.L
- 1D
- 2.31%
- 1M
- -0.09%
- YTD
- 8.47%
- 6M
- 9.69%
- 1Y
- 23.59%
- 3Y*
- 19.24%
- 5Y*
- 11.24%
- 10Y*
- —
NVO vs. CW8U.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | -10.74% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -1.73% |
CW8U.L Amundi MSCI World UCITS USD | 8.47% | 20.32% | 19.03% | 24.06% | -18.23% | 22.09% | 15.78% | 28.00% | -9.23% |
Correlation
The correlation between NVO and CW8U.L is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Apr 26, 2018 | 0.21 |
The correlation between NVO and CW8U.L shifts across timeframes, from 0.19 (3 years) to 0.33 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. CW8U.L — Risk / Return Rank
NVO
CW8U.L
NVO vs. CW8U.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Amundi MSCI World UCITS USD (CW8U.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | CW8U.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.72 | ||
| Sortino ratioReturn per unit of downside risk | -3.90 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.34 | -0.49 |
| Calmar ratioReturn relative to maximum drawdown | -0.80 | 2.70 | -3.50 |
| Martin ratioReturn relative to average drawdown | -1.18 | 11.32 | -12.50 |
Loading charts...
Drawdowns
NVO vs. CW8U.L - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, which is greater than CW8U.L's maximum drawdown of -34.10%. Use the drawdown chart below to compare losses from any high point for NVO and CW8U.L.
Loading charts...
Drawdown Indicators
| NVO | CW8U.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -34.10% | -40.60% |
Max Drawdown (1Y)Largest decline over 1 year | -54.34% | -8.48% | -45.86% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -17.26% | -57.44% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -25.79% | -48.91% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | — | — |
Current DrawdownCurrent decline from peak | -68.11% | -1.62% | -66.49% |
Average DrawdownAverage peak-to-trough decline | -17.79% | -5.03% | -12.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.62% | 2.03% | +35.59% |
Volatility
NVO vs. CW8U.L - Volatility Comparison
Novo Nordisk A/S (NVO) has a higher volatility of 10.68% compared to Amundi MSCI World UCITS USD (CW8U.L) at 4.07%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than CW8U.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | CW8U.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.68% | 4.07% | +6.61% |
Volatility (6M)Calculated over the trailing 6-month period | 38.04% | 9.57% | +28.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.88% | 12.18% | +39.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.33% | 15.68% | +22.65% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.56% | 16.77% | +15.79% |
Dividends
NVO vs. CW8U.L - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 4.11%, while CW8U.L has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CW8U.L Amundi MSCI World UCITS USD | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 4.11% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Frequently Asked Questions
NVO and CW8U.L have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NVO and CW8U.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer